Pan-Cancer Multi-Omics and Structure-Guided Drug Discovery Identify TUBG1 as a Clinically and Immunologically Relevant TargetMuhammad Alaa Eldeen, Bonglee Kim, Soha Y. Alkhaldi et al.|Journal of Computational Biophysics and Chemistry|2026Cited by 0